| ID |
CIA |
College |
Faculty |
School/Dept |
Project Title (Scientific Title) |
2005 |
2006 |
2007 |
2008 |
2009 |
Total received $ |
| 352479 |
Dr Peter Yun |
CHS |
Dentistry |
|
Porphyromonas finfivalis cysteine proteinases in modulation of cell-mediated immune response in periodontitis |
$74,750 |
$74,750 |
$74,750 |
|
|
$224,250 |
| 352576 |
A/Prof Christopher Maher |
CHS |
FHS |
Physiotherapy |
A clinical trial of manipulative therapy and/or NSAIDs for significant acute low back pain |
$185,375 |
$275,375 |
$60,875 |
|
|
$521,625 |
| 352584 |
Prof Mark Onslow |
CHS |
FHS |
Stuttering Research Centre |
A telehealth adaptation of a treatment for chronic stuttering |
$137,550 |
$122,550 |
$122,550 |
|
|
$382,650 |
| 352312 |
A/Prof Mark Gillies |
CHS |
Medicine |
Central Clinical School |
A multicentre randomised clinical trial of laser treatment plus intravitreal traimcilone for diabetic macular oedema |
$140,250 |
$150,250 |
$150,250 |
$80,750 |
|
$521,500 |
| 352331 |
A/Prof Scott Menzies |
CHS |
Medicine |
Central Clinical School |
Crossover trial of dermoscopy and short-term digital monitoring for the management of skin lesions in general practice |
$152,450 |
$38,300 |
|
|
|
$190,750 |
| 352354 |
Dr Lesley Wright |
CHS |
Medicine |
Central Clinical School |
Regulation of secretion of the fungal virulence determinant, phospholipase B |
$160,250 |
$160,250 |
$160,250 |
|
|
$480,750 |
| 352342 |
Prof David Le Couteur |
CHS |
Medicine |
Central Clinical School, ANZAC Research Institute |
Mechanisms for ageing changes in the hepatic sinusoid |
$139,250 |
$134,250 |
$134,250 |
|
|
$407,750 |
| 352343 |
Prof David Le Couteur |
CHS |
Medicine |
Central Clinical School, ANZAC Research Institute |
How is lipoprotein disposition influenced by fenestrae in the hepatic sinusoidal endothelium? |
$102,000 |
$102,000 |
$102,000 |
|
|
$306,000 |
| 352322 |
Dr Colin Dunstan |
CHS |
Medicine |
Central Clinical School, ANZAC Research Institute |
Bone resorption in breast cancer metastasis |
$141,650 |
$141,650 |
$136,650 |
|
|
$419,950 |
| 358307 |
Dr Cecile King |
CHS |
Medicine |
Central Clinical School, Centenary Institute |
The role of Interleukin-21 in the pathogenesis of autoimmune diabetes |
$170,500 |
$170,500 |
$170,500 |
|
|
$511,500 |
| 358300 |
A/Prof John Rasko |
CHS |
Medicine |
Central Clinical School, Centenary Institute |
Micro RNAs in normal and neoplastic myelopoiesis |
$135,625 |
$135,625 |
$135,625 |
|
|
$406,875 |
| 358304 |
A/Prof Chris Semsarian |
CHS |
Medicine |
Central Clinical School, Centenary Institute |
Genetic basis of sudden cardiac death in the young |
$189,250 |
$189,250 |
$189,250 |
|
|
$567,750 |
| 358327 |
Dr Michael Davies |
CHS |
Medicine |
Central Clinical School, Heart Research Institute |
Damage to arterial extracellular matrix induced by reactive nitrogen species and its consequences |
$107,000 |
$107,000 |
$107,000 |
|
|
$321,000 |
| 358330 |
Dr Kenneth Rodgers |
CHS |
Medicine |
Central Clinical School, Heart Research Institute |
Mechanisms of oxidised accumulation in ageing cells |
$140,500 |
$140,500 |
$140,500 |
|
|
$421,500 |
| 352409 |
Dr Guy Marks |
CHS |
Medicine |
Central Clinical School, Woolcock Institute |
Environmental influences on allergic airways disease from birth to 8yrs: long-term outcomes of a randomised trial (CAPS) |
$159,250 |
$181,500 |
$181,500 |
|
|
$522,250 |
| 352483 |
Dr Naomi Rogers |
CHS |
Medicine |
Central Clinical School, Woolcock Institute |
Effects of circadian disruption and sleep deprivation in respiratory disorders |
$134,000 |
$134,000 |
$134,000 |
|
|
$402,000 |
| 352427 |
Dr Euan Tovey |
CHS |
Medicine |
Central Clinical School, Woolcock Institute |
Exploration of exposures associated with bedding that are risks for childhood allergy asthma symptoms |
$149,500 |
$109,625 |
|
|
|
$259,125 |
| 352491 |
Prof Peter Gunning |
CHS |
Medicine |
CHW Clinical School |
Molecular genetics of cell and tissue structure |
$205,375 |
$205,375 |
$205,375 |
$205,375 |
$205,375 |
$1,026,875 |
| 352391 |
Dr David Little |
CHS |
Medicine |
CHW Clinical School |
Relationship of the anabolic and catabolic responses in healing a critical sized defect in rats |
$111,750 |
$111,750 |
$101,750 |
|
|
$325,250 |
| 352383 |
A/Prof Chandini MacIntyre |
CHS |
Medicine |
CHW Clinical School |
The immunogenicity of 7-valent pneumococcal conjugate vaccine in sick elderly people for whom vaccine is not registered. |
$147,550 |
$159,500 |
$129,500 |
|
|
$436,550 |
| 352351 |
Prof David Burke |
CHS |
Medicine |
Central Clinical School |
Changes in motoneurone and motor axon properties distal to the lesion in stroke |
$115,625 |
$115,625 |
$115,625 |
|
|
$346,875 |
| 352473 |
Prof Graham Johnston |
CHS |
Medicine |
Medical Sciences |
Cage compounds as blockers of GABA and glycine receptor channels |
$170,500 |
$170,500 |
$170,500 |
|
|
$511,500 |
| 352496 |
A/Prof Nicholas King |
CHS |
Medicine |
Medical Sciences |
Immunobiology of early pregnancy-a model of virus-induced abortion |
$149,250 |
$149,250 |
$149,250 |
|
|
$447,750 |
| 352447 |
A/Prof Rebecca Mason |
CHS |
Medicine |
Medical Sciences |
Photoprotection by vitamin D and analogs |
$95,400 |
$95,400 |
$95,400 |
|
|
$286,200 |
| 358372 |
A/Prof Ian Cameron |
CHS |
Medicine |
Northern Clinical School |
Improving adherence with the use of hip protectors, in community, residential aged care and hospital settings |
$243,500 |
$156,250 |
|
|
|
$399,750 |
| 352550 |
Dr Simon Finfer |
CHS |
Medicine |
Northern Clinical School |
Multicentre, open label, randomised, controlled trial of severe ARF management with an augmented vs normal CRRT regimen. |
$611,500 |
$709,100 |
$440,500 |
$107,375 |
|
$1,868,475 |
| 358389 |
Prof Eileen Gallery |
CHS |
Medicine |
Northern Clinical School |
Why is trophoblast invasion defective in pregnancies that develop pre-eclampsia? |
$169,250 |
$164,250 |
$164,250 |
|
|
$497,750 |
| 352562 |
Dr James Melrose |
CHS |
Medicine |
Northern Clinical School |
Pathobiology of the small leucine rich repeat proteoglycans in cartilage, intervertebral disc and tendon degeneration |
$144,500 |
$171,250 |
$193,000 |
|
|
$508,750 |
| 358378 |
Prof Jonathan Morris |
CHS |
Medicine |
Northern Clinical School |
A randomised controlled trial of immediate delivery versus expectant care in women with ruptured membranes close to term. |
$252,100 |
$252,100 |
$252,100 |
|
|
$756,300 |
| 358392 |
A/Prof Christopher O'Neill |
CHS |
Medicine |
Northern Clinical School |
Role of tumour suppressor genes in early embryopathy |
$134,000 |
$134,000 |
$134,000 |
|
|
$402,000 |
| 352320 |
A/Prof Christopher Liddle |
CHS |
Medicine |
Pharmacology |
Expression and regulation of human genes central to drug disposition in the brain |
$111,500 |
$111,500 |
$111,500 |
|
|
$334,500 |
| 352437 |
Prof Basil Donovan |
CHS |
Medicine |
Public Health |
The health impact of prostitution laws |
$143,150 |
$148,650 |
$113,650 |
|
|
$405,450 |
| 352341 |
Dr Allison Abendroth |
CHS |
Medicine |
Western Clinical School |
Immunopathogenesis of varicella zoster virus infection |
$117,000 |
$112,000 |
$112,000 |
|
|
$341,000 |
| 352326 |
Dr Linda Bendall |
CHS |
Medicine |
Western Clinical School |
CXCR4 antagonists in acute lymphoblastic leukemias in NOD/SCID mice |
$165,750 |
$165,750 |
$165,750 |
|
|
$497,250 |
| 352428 |
A/Prof Christine Clarke |
CHS |
Medicine |
Western Clinical School |
Progesterone receptor action in the normal human breast |
$59,500 |
$145,250 |
$150,250 |
|
|
$355,000 |
| 358351 |
Prof Gwendolyn Gilbert |
CHS |
Medicine |
Western Clinical School |
Translating bacterial molecular epidemiology into information to improve infectious disease risk assessment and control |
$169,250 |
$159,250 |
$159,250 |
|
|
$487,750 |
| 352337 |
Prof Richard Lindley |
CHS |
Medicine |
Western Clinical School |
Retinal microvascular signs in acute stroke: prognostic significance and relevance to underlying pathophysiology |
$124,150 |
$126,650 |
$117,950 |
|
|
$368,750 |
| 352303 |
Dr Wieland Meyer |
CHS |
Medicine |
Western Clinical School |
Phylogeny as a basis for molecular identification of pathogenic fungi |
$148,250 |
$148,250 |
$138,250 |
|
|
$434,750 |
| 352419 |
Dr Graham Robertson |
CHS |
Medicine |
Western Clinical School |
Repression of hepatic drug metabolism by solid tumours |
$165,500 |
$165,500 |
$165,500 |
|
|
$496,500 |
| 358352 |
A/Prof Graeme Stewart |
CHS |
Medicine |
Western Clinical School |
Genes associated with multiple sclerosis |
$158,250 |
$190,500 |
$215,500 |
|
|
$564,250 |
| 352386 |
Prof William Tarnow-Mordi |
CHS |
Medicine |
Western Clinical School |
Which oxygen saturation level should we use for very premature infants? A randomised controlled trial |
$494,413 |
$510,263 |
$525,263 |
$336,163 |
$336,163 |
$2,202,265 |
| 352330 |
Prof James Wiley |
CHS |
Medicine |
Western Clinical School |
Role of P2X7 in innate and adaptive immunity to myobacterial infections |
$155,250 |
$155,250 |
$155,250 |
|
|
$465,750 |
| 352407 |
Prof Doug Elliott |
CHS |
Nursing |
Clinical Nursing |
Testing a home based rehabilitation program for survivors of a critical illness: a randomised controlled trial |
$142,550 |
$132,550 |
$63,775 |
|
|
$338,875 |
| 352434 |
Dr Jules M Guss |
CST |
Science |
Molecular & Microbial Bioscience |
Structural characterisation of a natural inhibitor of sporulation bound to its histidine kinase target |
$85,750 |
$85,750 |
$85,750 |
|
|
$257,250 |
| 352352 |
Dr Ruth Hall |
CST |
Science |
Molecular & Microbial Bioscience |
Structure, formation and evolution of multiple antibiotic and mercury resistance regions in gram-negative bacteria |
$180,700 |
$180,700 |
$180,700 |
|
|
$542,100 |
| 352475 |
A/Prof Iain McGregor |
CST |
Science |
Psychology |
Ecstacy, methamphetamine and their combination: assessment of adverse effects |
$133,000 |
$123,000 |
$123,000 |
|
|
$379,000 |
| 352486 |
Dr Vivienne Reeve |
CST |
Vet Science |
|
The regulatory mechanisms of haem oxygenase protection against photoimmunosupression and skin cancer |
$144,250 |
$144,250 |
$144,250 |
|
|
$432,750 |